Drugs for RTI Flashcards
Broad spectrum antibiotics have higher risk for superinfection like pseudomembranous colitis. Besides, antibiotic induced alteration of normal flora may cause invasion of opportunistic pathogens like Clostridium difficile (caused by clindamycin), Candida etc. Antibiotics with high risk of pseudomembranous colitis are
clindamycins
fluoroquinolones (ciprofloxacin, levofloxacin)
beta lactams (aminopenicillins like ampicillin, cephalosporins, carbapenems)
drugs to treat pseudomembranous colitis?
metronidazole
vancomycin
Groups of antibiotics with low risk of superinfection?
macrolides
tetracyclines
sulfonamides
penicillin’s activity is limited due to bacterial resistance, which microorganisms are resistant to it?
staphylococci
neisseria gonorrhea
how to prevent antimicrobial resistance?
-used only when indicated, in sufficiently high dose for sufficient time
-prefer rapidly acting & narrow spectrum drugs
-use combination of antibacterial agents whenever prolonged therapy
Groups of antibiotics commonly used for RTI? (sem 2)
beta lactams:
1. penicillin
2. cephalosporin
3. carbapenem
4. monobactam
glycopeptides: vancomycin, teicoplanin
ALL inhibit cell wall synthesis
RTI divided into bacterial and viral. Bacterial infection is subdivided into community-acquired & hospital-acquired. List the rational treatment of bacterial pneumonia.
listed below are all 1st line drugs
CAP:
outpatient>aminopenicillins (amoxicillin)
inpatient> aminopenicillins (amoxicillin)+macrolides (azithromycin)
HAP/VAP:
amoxicillin/clavulanate
cephalosporins 4th gen eg. cefepime
Aspiration pneumonia:
amoxicillin/clavulanate
Bacterial cell wall structure difference in gram-positive and negative?
+ thick peptidoglycan cell wall
- thin peptidoglycan cell wall with a outer membrane
Stages of bacterial cell wall synthesis?
first stage
synthesis of peptidoglycan monomer intracellularly
second stage
peptidoglycan monomers are joined to form peptidoglycan chains at the outer surface of membrane (glycopeptide)
third stage
peptidoglycan chains are cross-linked by transpeptidase (penicillin binding protein PBP) at the outer surface of membrane ( beta lactam )
Beta lactam antibiotics target
PBP, preventing final crosslinking of peptidoglycan, inhibiting peptidoglycan cell wall synthesis
beta lactam antibiotics have no use against two things:
- atypical bacteria like Legionella, Mycoplasma, Chlamydia as they do not have peptidoglycan cell wall
- MRSA except ceftaroline fosamil due to its ability to bind & block PBP2A in MRSA
MOA of beta lactam antibiotics
- PBP catalyses the last step of peptidoglycan synthesis/cross-linking
- beta lactam antibiotics irreversibly bind to active site of PBP
- inhibit PBP, prevent final crosslinking of peptidoglycan, prevent synthesis of bac cell wall
- disruption of bac cell [bactericidal effect]
Bacterial resistance against beta lactam antibiotics due to two reasons:
- beta-lactamase production
-beta-lactamase/penicillinases hydrolyse beta lactam antibiotics
-producers of the enzymes : staph, neisseria gonorrhoea, E.coli, pseudomonas aeruginosa - alteration of PBP structure
-MRSA have PBP2A (an altered struc of PBP)
-most beta lactam antibiotics cannot bind to PBP2A hence not effective against MRSA
Types of penicillins
- natural penicillin
Eg: penicillin G, penicillin V
+/- (mostly +)
ineffective against S. aureus - anti-staphylococcal penicillin
Eg: cloxacillin
resistant to beta lactamases
treat staph infection EXCEPT MRSA - extended spectrum penicillin/aminopenicillin
Eg: amoxicillin+clavalunate
+/-
treat non-complicated community acquired infection
Empirical treatment for lung abscess pneumonia - anti-pseudomonal penicillin
Eg: piperacillin
-
treat P. aeruginosa infections, HAP
ADR of penicillins
-wide therapeutic index, safe
-no tetragenic, safe in pregnancy and breastfeeding
-anaphylaxis
-allergic cross-reactions with other beta lactams
-pseudomembranous colitis caused by Clostridium difficile!!!
inhibitors of beta-lactamase
THEY ARE NOT ANTIBIOTICS
clavulanic acid
sulbactam
tazobactam
- most effective against plasmid-encoded beta lactamases
- inactive against type I chromosomal beta-lactamases produced by gram - bac like enterobacter, acinetobacter, pseudomonas
use of inhibitors of beta-lactamase
to extend activity of beta-lactam antibiotics against the beta lactamse producing strain
Is AMOXICILLIN CLAVULANATE effective in treatment of MRSA?
no, MRSA have altered structure of PBP called PBP2A. Beta lactam cannot inhibit site of synthesis of peptidoglycan, it can only inhibit PBP